<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>therapies &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/therapies/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Oct 2026 15:08:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>therapies &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Diabetes May Drive Dementia Through Brain Insulin Resistance and Tau Changes</title>
		<link>https://bioengineer.org/diabetes-may-drive-dementia-through-brain-insulin-resistance-and-tau-changes/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 15:08:04 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[associated]]></category>
		<category><![CDATA[cognitive]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[emerging]]></category>
		<category><![CDATA[impairment]]></category>
		<category><![CDATA[Pathophysiology]]></category>
		<category><![CDATA[scientific research]]></category>
		<category><![CDATA[therapies]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=428930</guid>

					<description><![CDATA[Diabetes is far more than a disorder of blood sugar. In a sweeping narrative review published in Annals of Clinical and Translational Neurology, researchers argue that diabetes-associated cognitive impairment, or DACI, should be understood as a spectrum of brain dysfunction]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">428930</post-id>	</item>
		<item>
		<title>PD-1/PD-L1 Inhibitors Show Greater-Than-Additive Synergy With Conventional Therapies in Esophageal Squamous Cell Carcinoma</title>
		<link>https://bioengineer.org/pd-1-pd-l1-inhibitors-show-greater-than-additive-synergy-with-conventional-therapies-in-esophageal-squamous-cell-carcinoma/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 14:14:30 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[carcinoma]]></category>
		<category><![CDATA[cell]]></category>
		<category><![CDATA[Combining]]></category>
		<category><![CDATA[conventional]]></category>
		<category><![CDATA[esophageal]]></category>
		<category><![CDATA[inhibitors]]></category>
		<category><![CDATA[PD-1]]></category>
		<category><![CDATA[PD-L1]]></category>
		<category><![CDATA[potential]]></category>
		<category><![CDATA[squamous]]></category>
		<category><![CDATA[Synergistic]]></category>
		<category><![CDATA[therapies]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=428211</guid>

					<description><![CDATA[A new narrative review synthesizes clinical trial evidence showing that combining PD-1/PD-L1 immune checkpoint inhibitors with chemotherapy, radiotherapy, and surgery produces synergistic, greater-than-additive effects in esophageal squamous cell carcinoma, now a standard first-line strategy for advanced disease.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">428211</post-id>	</item>
	</channel>
</rss>
